Bob Peterson has an extensive background in finance with a variety of experiences from Financial Services, Pharmaceutical/Medical Device and Telecommunications industries. Prior to joining Virbac, he was the Senior Finance Director for Elevate Credit International Limited where he served as a key member of the UK Executive Leadership Team setting the strategy and direction of the business. While at Elevate Credit, he utilized advanced analytical capabilities to drive improvements via predictive models, driving tangible benefits to the bottom line. Prior to Elevate, Bob held various roles at Alcon Laboratories, Inc./Novartis (Eye Care Division) within Investor Relations, Global Planning and Analysis, Controlling and Audit.
In his role as Chief Financial Officer for Virbac Corporation, Mr. Peterson is responsible for defining and maintaining efficient processes designed to provide accurate information, proper control and compliance, and evaluation of the risks and rewards of operational actions and strategic options in order to support business decision making.
This website uses cookies necessary for the proper functioning of the site and to facilitate your navigation. You will find more information about cookies, how we use them and how you can control their use by clicking on the following link: Cookies. By continuing your visit to this site, you agree that we use cookies, as specified in our policy.
Bob Peterson has an extensive background in finance with a variety of experiences from Financial Services, Pharmaceutical/Medical Device and Telecommunications industries. Prior to joining Virbac, he was the Senior Finance Director for Elevate Credit International Limited where he served as a key member of the UK Executive Leadership Team setting the strategy and direction of the business. While at Elevate Credit, he utilized advanced analytical capabilities to drive improvements via predictive models, driving tangible benefits to the bottom line. Prior to Elevate, Bob held various roles at Alcon Laboratories, Inc./Novartis (Eye Care Division) within Investor Relations, Global Planning and Analysis, Controlling and Audit.